Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITDAOperating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HUTCHMED (China) (HCM) EBIT: 2014-2024

Historic EBIT for HUTCHMED (China) (HCM) over the last 11 years, with Dec 2024 value amounting to -$43.7 million.

  • HUTCHMED (China)'s EBIT was N/A to -$252.5 million in Q4 2021 from the same period last year, while for Dec 2021 it was $341.0 million, marking a year-over-year change of. This contributed to the annual value of -$43.7 million for FY2024, which is 337.85% down from last year.
  • Per HUTCHMED (China)'s latest filing, its EBIT stood at -$43.7 million for FY2024, which was down 337.85% from $18.4 million recorded in FY2023.
  • In the past 5 years, HUTCHMED (China)'s EBIT registered a high of $18.4 million during FY2023, and its lowest value of -$407.7 million during FY2022.
  • In the last 3 years, HUTCHMED (China)'s EBIT had a median value of -$43.7 million in 2024 and averaged -$144.3 million.
  • As far as peak fluctuations go, HUTCHMED (China)'s EBIT spiked by 104.51% in 2023, and later crashed by 337.85% in 2024.
  • HUTCHMED (China)'s EBIT (Yearly) stood at -$196.7 million in 2020, then slumped by 66.94% to -$328.3 million in 2021, then declined by 24.18% to -$407.7 million in 2022, then spiked by 104.51% to $18.4 million in 2023, then crashed by 337.85% to -$43.7 million in 2024.